Clinical Trial Update: Study of the 532 nm KTP Laser for the Treatment of Poikiloderma of Civatte [NA]

View source ↗

Summary

Completed clinical trial evaluating a 532 nm KTP laser for treating Poikiloderma of Civatte and associated dyschromia/pigmentation issues; results posted in 202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyschromia
• Photosensitivity Disorders
• Pigmentation Disorders
• Poikiloderma of Civatte
• Telangiectasia

Drugs mentioned

• 532-nm KTP laser (KTP laser)

Snippet

Sponsor: Cutera Inc. | Conditions: Poikiloderma of Civatte, Dyschromia | NA | Status: COMPLETED | Results posted: 2022-10-28